Biotech · Private company
Nanobiotix
Track this companyFree. Adds Nanobiotix to your Dealase workspace and tells you when its record changes.
Clinical trials32 recruiting or active
Pipeline programs6From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline6
- NBTXR3 activated by Brachytherapy & IMRTPhase 2 · Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
- NBTXR3 activated by IMRT onlyPhase 2 · Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
- NBTXR3Phase 1 · RadiotherapyClinicalTrials.gov · fetched Nov 12, 2026
- NivolumabPhase 1 · RadiotherapyClinicalTrials.gov · fetched Nov 12, 2026
- PembrolizumabPhase 1 · RadiotherapyClinicalTrials.gov · fetched Nov 12, 2026
- SABRPhase 1 · RadiotherapyClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- NBTXR3 With Radiation Therapy Alone for Locally-advanced Non-small Cell Lung CancerPHASE1_PHASE2 · RECRUITING · started Mar 27, 2026ClinicalTrials.gov NCT07224152 · fetched Nov 12, 2026
- NBTXR3 Activated by Radiotherapy for Patients With Advanced Cancers Treated With An Anti-PD-1 TherapyPHASE1 · ACTIVE_NOT_RECRUITING · started Jan 16, 2019ClinicalTrials.gov NCT03589339 · fetched Nov 12, 2026
- NBTXR3 Nanoparticles and EBRT or EBRT With Brachytherapy in the Treatment of Prostate AdenocarcinomaPHASE1_PHASE2 · TERMINATED · started Nov 15, 2017ClinicalTrials.gov NCT02805894 · fetched Nov 12, 2026